Pixium Vision Receives NUB Innovation Reimbursement Status-1 for 150 Electrode IRIS®II Bionic System in Germany

PARIS--(BUSINESS WIRE)--Regulatory News: Pixium Vision (Paris:PIX), a company developing innovative bionic vision systems with the intention to allow patients who have lost their sight to lead more independent lives, today announced that the German Institute for the Hospital Remuneration System (InEK) has granted NUB (Neue Untersuchungs- und Behandlungsmethoden) Status-1 for IRIS®II, Pixium Vision’s first bionic vision system, equipped with a bio-inspired camera and a 150 electrodes epi-retinal